Are Zymeworks BC Inc’shares a good deal?

Preston Campbell

While Zymeworks BC Inc has overperformed by 3.17%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, ZYME rose by 80.33%, with highs and lows ranging from $28.49 to $9.03, whereas the simple moving average jumped by 72.67% in the last 200 days.

On December 12, 2025, Wells Fargo Upgraded Zymeworks BC Inc (NASDAQ: ZYME) to Overweight. A report published by Citizens JMP on December 03, 2025, Initiated its previous ‘Mkt Outperform’ rating for ZYME. Wells Fargo also rated ZYME shares as ‘Equal Weight’, setting a target price of $15 on the company’s shares in an initiating report dated October 24, 2025. B. Riley Securities initiated its ‘Buy’ rating for ZYME, as published in its report on October 10, 2025. JP Morgan also rated the stock as ‘Overweight’.

Analysis of Zymeworks BC Inc (ZYME)

Further, the quarter-over-quarter increase in sales is 72.59%, showing a positive trend in the upcoming months.

Zymeworks BC Inc’s future performance can be determined with the help of several well-rounded types of analysis and research techniques, with equity being one of the most influential. The goal here is to ensure that your current return on equity of -18.46% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 6.94, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.

The average volume for any stock is also a very valuable indicator of volatility, and ZYME has an average volume of 1.14M. On a monthly basis, the volatility of the stock is set at 4.86%, whereas on a weekly basis, it is put at 4.15%, with a gain of 5.85% over the past seven days. Furthermore, long-term investors anticipate a median target price of $35.54, showing growth from the present price of $26.4, which can serve as yet another indication of whether ZYME is worth investing in or should be passed over.

How Do You Analyze Zymeworks BC Inc Shares?

In addition to analyzing the fundamentals, it is also important to look at how many company employees own stock. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 3.31%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 99.50% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.

US Post News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.